# Tirosint

NDC: 71858-0010
Generic name: levothyroxine sodium
Labeler / Manufacturer: IBSA Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20181201

FDA application: NDA021924

## Active ingredients

- LEVOTHYROXINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71858-0010"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71858-0010
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a7ade79-0165-4e31-b84e-667416c00c7e